Evidence map›Paper›PMID 37833606›Full record

ArticleDoklady. Biochemistry and biophysics2023

Contributing Factors of Diabetes Mellitus among Patients with Gout (Results of the Long-Term Prospective Study).

O V Zheliabina, M S Eliseev, S I Glukhova, E L Nasonov

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

O V ZheliabinaNasonova Research Institute of Rheumatology, Moscow, Russia. olga-sheliabina@mail.ru.
M S EliseevNasonova Research Institute of Rheumatology, Moscow, Russia.
S I GlukhovaNasonova Research Institute of Rheumatology, Moscow, Russia.
E L NasonovNasonova Research Institute of Rheumatology, Moscow, Russia.
Association of Rheumatologists of Russia · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is assumed that the risk of developing type 2 diabetes mellitus (T2DM) in patients with gout is influenced by both generally accepted risk factors and factors related to gout. The aim of the study was to evaluate the impact of various risk factors for T2DM in patients with gout. A total of 444 patients (49 women, 395 men) ≥18 years old with gout and without DM were included. The duration of observation was 5.66 [2.69; 7.64] years. To identify the factors associated with the risk of developing T2DM, multivariate logistic regression was used, which included sex; T2DM in relatives; insufficient physical activity; unbalanced diet; age  ≥ 45 years; ≥4 attacks per year; presence of tophi; BMI ≥30 kg/m

Indexed as

Diabetes Mellitus, Type 2GoutMetforminAdolescentDiureticsFebuxostatFemaleGout SuppressantsHumansMaleMiddle AgedProspective StudiesUric AcidDiureticsFebuxostatGout SuppressantsMetforminUric Acidgouttype 2 diabetes mellitusuric acid

Identifiers

PMID37833606
PMCPMC10739371
OpenAlexW4387621301

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.